Promises and pitfalls of anti-angiogenic therapy in clinical trials

By McCarty M.F.   Liu W.   Fan F.   Parikh A.   Reimuth N.   Stoeltzing O.   Ellis L.M.  

Trends in Molecular Medicine, Vol. 9, Iss. 2, 2003-02 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite

Towards More Successful Gene Therapy Clinical Trials for &bgr;-Thalassemia

By  

Current Molecular Medicine, Vol. 13, Iss. 8, 2013-09 ,pp. : 1314-1330

Bentham Science Publishers

Access to resources Recommend Favorite

Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation

By Fischer S.   Hopkinson D.   Cassivi S.D.   Saad S.   Paul A.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2817-2819

Elsevier

Access to resources Recommend Favorite

The COAG and EU-PACT Trials: What is the Clinical Benefit of Pharmacogenetic-Guided Coumarin Dosing During Therapy Initiation?

By  

Current Molecular Medicine, Vol. 14, Iss. 7, 2014-08 ,pp. : 841-848

Bentham Science Publishers

Access to resources Recommend Favorite

Pancreas Transplantation Without Antibody Therapy

By Corry R.J.   Shapiro R.   Egidi M.F.   Jordan M.L.   Scantlebury V.   Vivas C.   Gritsch H.A.   Starzl T.E.  

Transplantation Proceedings, Vol. 30, Iss. 2, 1998-03 ,pp. : 299-300

Elsevier

Access to resources Recommend Favorite